Sam Heughan is the Radio Times TV Champion 2015   7 comments

Sam Heughan is the Radio Times TV Champion 2015


From Radio Times

The star of the Scottish time travel drama trumped Comedy Champion Ricky Gervais with 16 million votes in the TV Champion Final

The Outlander star stormed the competition, with his fans racking up millions of votes for him to win Sci-Fi and Fantasy Champion before casting an astonishing 16.5 MILLION votes for him in an epic three day final battle with Ricky Gervais.

“Congratulations to all the competitors in the Radio Times Competition!! Wow. A true list of the most popular and greatest shows/cast on TV” said Heughan, who emerged victorious from the final rounds, during which more than 60 million votes were cast.

“I’m honored and a little, no VERY astonished at the number of votes cast by our dedicated and passionate fans! Can’t thank them enough – many have no fingers left due to intense voting – “Tapadh leibh” to you all!”

Read the rest of the article here

7 responses to “Sam Heughan is the Radio Times TV Champion 2015

Subscribe to comments with RSS.

  1. Reblogged this on Ana Fraser Lallybroch Blog.

  2. Reblogged this on Barabal's Blog.

  3. Hip hip hooray! Hip hip hooray! True talent always wins out!

  4. A cover for Sam & Outlander!!!!!

  5. A well deserved award! Congratulations Sam!!

  6. I am a fundraiser and supporter of LLS. Support Sam’s charity with online donations to your local or national LLS.

    September is Blood Cancer Awareness Month. It’s a month during which we will show you proof of the impact your support can have; an impact that reverberates through the entire field of cancer study.
    Blood cancer research is the leading edge of cancer research. It is helping us reach a new understanding about the genetic makeup of the disease and how to treat it.
    Here’s some proof of impact:
    • Therapies developed through LLS-funded research are now showing promise in other cancers, such as breast, lung, pancreatic, prostate and ovarian cancer.
    • Nearly 40% of new cancer therapies approved by the FDA between 2000 and 2014 were first approved for blood cancer patients.
    • LLS-funded researchers have helped advance targeted therapies for patients with chronic myeloid leukemia and other B-cell cancers, and have received FDA approval for these therapies in just the past two years.
    These advances were only made possible because of your continued support. Help us keep the momentum going. Join us and help us prove that leading-edge research is conquering cancer and saving lives

  7. Pinned onto Outlander the Series.

Leave a Reply